🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

951 results for “Eli” Clear

  1. Vonoprazan and Amoxicillin for the first 7 days

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    1 trial

  2. XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

    Pfizer Australia Pty Ltd

    This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

    approved small molecule active

    1 trial

  3. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    approved other active

    1 trial

  4. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved other completed

    1 trial

  5. dexmedetomidine hydrochloride for injection

    The First People's Hospital of Lianyungang

    Delirium

    approved small molecule completed

    1 trial

  6. premeal insulin lispro mixtures

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  7. sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab active

    3 trials

  8. sIPV vaccine /DTaP vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab completed

    1 trial

  9. Carrelizumab

    The First People's Hospital of Lianyungang

    Cholangiocarcinoma

    small molecule active

    1 trial

  10. Carrelizumab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    small molecule active

    1 trial

  11. Daphne Extract Capsules

    The First People's Hospital of Lianyungang

    Epithelial Ovarian Cancer

    small molecule active

    1 trial

  12. Desflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Delirium

    small molecule active

    1 trial

  13. Dexmedetomidine injection

    United Therapeutics Europe Ltd

    Delirium in Old Age

    small molecule completed

    1 trial

  14. Disitamab Vedotin combined with Zimberelizumab

    The First People's Hospital of Lianyungang

    Biliary Carcinoma

    small molecule active

    1 trial

  15. Efgartigimod + Telitacicept (1-week interval) group

    The First People's Hospital of Lianyungang

    Myasthenia Gravis

    small molecule active

    1 trial

  16. Generic cetrorelix acetate

    NORTHWEST BIOTHERAPEUTICS INC

    Infertility

    small molecule active

    1 trial

  17. Gluten

    Takeda

    Celiac Disease

    other completed

    1 trial

  18. Gluten Powder

    Regeneron UK Limited

    Celiac Disease

    other completed

    1 trial

  19. Goserelin

    The First People's Hospital of Lianyungang

    Allogeneic Haematopoietic Stem Cell Transplantation

    small molecule active

    1 trial

  20. Goserelin 3.6 mg implant

    Universal Integrated

    Postpartum Depression

    small molecule completed

    1 trial

  21. Group A (clinical guideline+machine learning)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    other active

    1 trial

  22. Guideline-directed medical therapy

    The First People's Hospital of Lianyungang

    Heart Failure With Reduced Ejection Fraction

    small molecule active

    1 trial

  23. Improved warm meridians and relieve pain plaster

    Universal Integrated

    Pelvic Inflammatory Disease

    small molecule active

    1 trial

  24. Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Lymphoma (PCNSL)

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources